what biogen halted its alzheimer's drug trial means for biotech investors
Published 5 years ago • 2.9K plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
2:54
biogen and eisai to reveal results of alzheimer's drug trial
-
3:20
biogen alzheimer's drug shows positive results
-
3:49
biogen ceo on fda approval for its alzheimer's drug
-
4:21
biogen soars on promising results from alzheimer's drug trial
-
1:21
biogen shares drop despite positive alzheimer's drug results
-
2:41
analyst on what biogen's alzheimer's drug means for the company
-
4:18
biogen's alzheimer's drug trial ripe for downside: analyst
-
7:54
biogen ceo michel vounatsos on seeking fda approval for new alzheimer's drug
-
7:54
alzheimer’s is not normal aging — and we can cure it | samuel cohen | ted talks
-
6:10
the science behind aduhelm, a controversial new alzheimer’s drug | wsj
-
6:38
how do you know if you have alzheimer disease
-
2:23
biogen to seek fda approval for alzheimer's drug aducanumab
-
1:34
biogen shares tumble as alzheimer's drug study is halted
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
2:12
jim cramer on fda resignations connected to the approval of biogen’s alzheimer’s drug
-
5:17
biogen ceo: alzheimer's drug shows positive results
-
4:32
fda's historic approval of biogen's alzheimer's drug
-
1:07
fda approves biogen's alzheimer's drug
-
3:40
here's what the fda's endorsement of the alzheimer's drug leqembi means for biogen
-
3:00
biogen shares drop as big clinics say they won't administer controversial alzheimer's drug
-
0:48
biogen alzheimer's drug closer to approval
-
1:48
biogen reopens following fda approval of company's alzheimer drug